XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenues $ 35,000 $ 31,300
Operating Expenses:    
Research and development 1,058,131 1,231,745
General and administrative 3,086,121 4,578,653
Total Operating Expenses 4,144,252 5,810,398
Loss From Operations (4,109,252) (5,779,098)
Other (Income) Expense:    
Interest income (162,597) (18,216)
Other income (149,021) (76,660)
Gain on exchange of warrants (1,711,698)
Change in fair value of derivative liabilities 137,319 1,488,350
Total Other (Income) Expense (1,885,997) 1,393,474
Net Loss $ (2,223,255) $ (7,172,572)
Net Loss Per Share - Basic $ (0.33) $ (1.93)
Net Loss Per Share - Diluted $ (0.33) $ (1.93)
Weighted Average Common Shares Outstanding - Basic 6,671,382 3,717,472
Weighted Average Common Shares Outstanding - Diluted 6,671,382 3,717,472